Prospective Multicenter Randomized All-Comers Trial to Assess the Safety and Effectiveness of the Ultra-Thin Strut Sirolimus-Eluting Coronary Stent Supraflex: Two-Year Outcomes of the TALENT Trial

Affiliations

• ¹ Department of Cardiology, Xijing hospital, Xi'an, China (C.G.).
• ² Department of Cardiology, Radboud University, Nijmegen, the Netherlands (C.G.).
• ³ Department of Cardiology, National University of Ireland Galway (C.G., F.S., Y.O., P.W.S.).
• ⁴ Amsterdam UMC, University of Amsterdam, the Netherlands (N.K., R.J.d.W.).
• ⁵ Maasstad Ziekenhuis, Rotterdam, the Netherlands (P.C.S.).
• ⁶ Department of Cardiology, Catharina Hospital, Eindhoven, the Netherlands (P.T.).
• ⁷ Medical Centre Leeuwarden, the Netherlands (S.H.).
• ⁸ Cardiology Department, La Paz University Hospital, Madrid, Spain (R.M.).
• ⁹ Department of Cardiology, University Hospital of Wales, Cardiff, United Kingdom (A. Choudhury).
• ¹⁰ Acibadem City Clinic Cardiovascular Center, Sofia, Bulgaria (I.P.).
• ¹¹ University Hospital of Bellvitge, Barcelona, Spain (A. Cequier).
• ¹² Division of Interventional Cardiology, Cardio-Thoracic-Vascular Department, San Raffaele Scientific Institute, Milan, Italy (A. Colombo).
• ¹³ Academics and Research, Batra Hospital and Medical Research Center, New Delhi, India (U.K.).
• ¹⁴ Freeman Hospital, Newcastle University, and Newcastle upon Tyne Hospitals NHS Trust, Newcastle, United Kingdom (A.Z.).
• ¹⁵ NHLI, Imperial College London, United Kingdom (P.W.S.).